PROCRIT (epoetin alfa)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for PROCRIT (epoetin alfa), covering 2011-05-19 to 2011-05-19. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Assess the Response Rate of PROCRIT (Epoetin Alfa) Given at a Dose of 40,000 Units Once a Week to Cancer Patients With Anemia Who Are Not Receiving Chemotherapy. [Phase 3]